Epidemiology of spina bifida in Tottori Prefecture, Japan, 1976-1995.

[1]  E. Mariman,et al.  PAX genes and human neural tube defects: an amino acid substitution in PAX1 in a patient with spina bifida. , 1996, Journal of medical genetics.

[2]  R. Behringer,et al.  Prenatal folic acid treatment suppresses acrania and meroanencephaly in mice mutant for the Cart1 homeobox gene , 1996, Nature Genetics.

[3]  M. den Heyer,et al.  Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida , 1995, The Lancet.

[4]  E. Mariman,et al.  A frameshift mutation in the gene for PAX3 in a girl with spina bifida and mild signs of Waardenburg syndrome. , 1995, Journal of medical genetics.

[5]  M. Levene,et al.  Prevention of neural-tube defects , 1993, The Lancet.

[6]  E. Haan,et al.  Prevalence of neural tube defects in South Australia, 1966-91: effectiveness and impact of prenatal diagnosis. , 1993, BMJ.

[7]  A. Czeizel,et al.  Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. , 1992, The New England journal of medicine.

[8]  J. Mulinare,et al.  Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. , 1992, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[9]  M. Gnant,et al.  Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study , 1991, The Lancet.

[10]  C. Davis,et al.  The changing incidence of neural tube defects in Scotland. , 1991, Journal of pediatric surgery.

[11]  A. Copp,et al.  A cell-type-specific abnormality of cell proliferation in mutant (curly tail) mouse embryos developing spinal neural tube defects. , 1988, Development.

[12]  Laurence Km.  The apparently declining prevalence of neural tube defect in two counties in South Wales over three decades illustrating the need for continuing action and vigilance. , 1985 .

[13]  A. Macleod,et al.  Seasonal variation in the frequency of anencephalus and spina bifida births in the United Kingdom. , 1984, Journal of epidemiology and community health.

[14]  B. Källén,et al.  Time trends of spina bifida in Sweden 1947-81. , 1984, Journal of epidemiology and community health.

[15]  A. Read,et al.  FURTHER EXPERIENCE OF VITAMIN SUPPLEMENTATION FOR PREVENTION OF NEURAL TUBE DEFECT RECURRENCES , 1983, The Lancet.

[16]  B. Källén,et al.  Clusters of malformations in Sweden: a study with central registers. , 1983, Environmental research.

[17]  T. Jenkins,et al.  Common birth defects in South African Blacks. , 1982, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[18]  L. Edmonds,et al.  Current trends in the incidence of neural tube defects. , 1982, Pediatrics.

[19]  R. Klein,et al.  Is myelomeningocele a disappearing disease? , 1982, Pediatrics.

[20]  N. Nevin,et al.  NEURAL TUBE DEFECTS , 1981, The Lancet.

[21]  J. Elwood,et al.  Epidemiology of Anencephalus and Spina Bifida , 1980 .

[22]  A. Read,et al.  POSSIBLE PREVENTION OF NEURAL-TUBE DEFECTS BY PERICONCEPTIONAL VITAMIN SUPPLEMENTATION , 1980, The Lancet.

[23]  Y. Imaizumi.  Statistical analysis on anencephaly, spina bifida and congenital hydrocephaly in Japan. , 1974, Jinrui idengaku zasshi. The Japanese journal of human genetics.

[24]  L. Naggan.  The recent decline in prevalence of anencephaly and spina bifida. , 1969, American journal of epidemiology.

[25]  Simpson Ca.  OYSTER AND VIRUS. , 1964 .

[26]  J. Neel.  A study of major congenital defects in Japanese infants. , 1958, American journal of human genetics.

[27]  Phillip I. Good,et al.  Clustering in Time and Space , 1994 .

[28]  J. de Swiet.  Letter: Therapy for acute diarrhoea. , 1975, Lancet.